Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because cannabis is still a schedule 1 drug in the U.S.,

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Veriheal

AUGUST 12, 2021

Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC. It goes by the name of “artisanal CBD.” .

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. We remain encouraged as we continue our evaluations of MYMD-1 for efficacy and safety – especially as studies continue to suggest we may be able to address many of the concerns that are associated with the current drugs on the market today in these disease areas.”.

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. The 2017 expansion of Virginia’s medical marijuana law got rid of qualifying conditions. So, we set about these two objectives, one being to add additional conditions.

Legalization 238

Legalization Marijuana Programs Oil 238

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. In response, veterinarians and others concerned for patient safety promoted a change in state law. Related story. Gary Richter, a Project CBD contributing writer, is an Oakland-based veterinarian.

Pets 220

Pets Legalization Hemp Extraction 220

Cannabis Law Report

AUGUST 17, 2021

.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. The Phase 2 TSC trial, the CALM trial, was an open-label trial to evaluate the safety and tolerability of adjunctive ganaxolone treatment in patients with seizures associated with TSC. About Marinus Pharmaceuticals.

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Cannabis Law Report

AUGUST 5, 2021

Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. What’s more, over the coming years psychedelics will continue to gain acceptance for treating these conditions which will also contribute to that market growth.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

WeedAdvisor

JULY 21, 2019

Marijuana may be a lucrative opportunity on the surface, but there are several conditions that could put the industry out of reach for some time. South America needs safe, reliable growing materials, cannot use certain pesticides, needs to meet cleanliness and safety standards, etc. Strict Regulations. .

Conditions 60

Conditions Seed-To-Sale Compliance Compliance 60

NORML

JANUARY 25, 2019

179: The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans. Opioid dependency was added to New Jersey’s list of conditions for medical cannabis eligibility. NH resident? NH resident? New Mexico.

Legislation 177

Legislation Patients Hemp Oil 177

PrestoDoctor

DECEMBER 12, 2023

Additionally, cannabis has shown promise in easing symptoms of chronic conditions such as arthritis, insomnia, and anxiety. Additionally, using cannabis for medical conditions does not mean THC must be consumed. CBD also plays an important role in management of conditions without the psychoactive high.

Medicine 98

Medicine Chronic Pain Consumption Pharmaceutical 98

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. “ Off-label use ” (which is extremely common) is: the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

Therapy 120

Therapy Legalization Chronic Pain DEA 120

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. Children who suffer from these conditions generally experience social and developmental delays due to constant seizures. What Does Epidiolex Treat?

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

NORML

JANUARY 11, 2019

Update : The Criminal Justice and Public Safety Committee will hold an executive session for HB 399 on 1/17 at 11am. The measure would allow Virginia’s licensed practitioners to recommend and pharmaceutical processors to dispense full therapeutic-strength medical cannabis oil. NH resident? New Mexico. NM resident?

Legislation 218

Legislation Decriminalization Hemp Patients 218

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

NORML

FEBRUARY 29, 2020

The bill allows the department of health to issue permits to medical cannabis dispensaries for the delivery of medical cannabis and cannabis products to qualifying patients or primary caregivers if certain conditions are met. Update : SB 2787 was approved by the Senate Judiciary Committee on 2/25/20. HI resident? NH resident? WV resident?

Legislation 156

Legislation Decriminalization Patients Programs 156

The Cannigma

MARCH 7, 2022

CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. How much this conversation takes place is not yet well studied and would vary based on many conditions.

THC 140

THC Clinical Trials Sleep Cannabinoids 140

MMJ Recs

JUNE 26, 2020

Marijuana Use In Safety Sensitive Job Duties In Oklahoma. Safety Sensitive jobs and work duties were detailed. Employers were given the legal right to take MMJ use into account when their employees would be engaged in Safety Sensitive work. What Are Safety Sensitive Jobs In Oklahoma MMJ Law? Dispensing pharmaceuticals.

Marijuana 69

Marijuana Safety Pharmaceutical Patients 69

Veriheal

MAY 17, 2021

Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” She ends the column by stating “ I urge our legislators to abandon this legislation for the sake of our citizen’s health and safety.”.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Veriheal

MARCH 18, 2021

Unfortunately, both of these conditions result in cognitive decline and suffer from a lack of effective treatment. This is a pretty common statement in most published research on cannabis as a possible treatment for conditions. Why Aging Cats?

CBD 109

CBD Research and Development Pets Treatment 109

Veriheal

NOVEMBER 10, 2020

The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice. .

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because cannabis is still a schedule 1 drug in the U.S.,

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

The Cannigma

MARCH 17, 2021

Postpartum depression (PPD) is not included as a qualifying condition for medical cannabis in any US state and much of what we know about whether or not cannabis can help treat PPD is anecdotal. Given the lack of safety information on the impact of cannabis on neonates and infants, breastfeeding when consuming cannabis is not recommended.

Research and Development 145

Research and Development Treatment Sleep Cannabis 145

Cannabis Law Report

AUGUST 16, 2021

The Ridgell case is an appeal of the Department of Child Safety’s decision to keep a former employee of the department on the registry. Her doctor prescribed medication for her condition, but she found that those did not relieve her symptoms, so she used cannabis to find relief. Help battle the Department of Child Safety.

Safety 116

Safety Patients Cannabis Law 116

NORML

FEBRUARY 1, 2019

Legislation has been reintroduced from last year, Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Last session, the measure was vetoed by Governor Brown. CA resident?

Legislation 185

Legislation Decriminalization Access Patients 185

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

DECEMBER 3, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Chief Executive Officer of Marinus Pharmaceuticals. “We Ganaxolone was generally well-tolerated and no new safety findings emerged in the LGS subgroup. ET (12:00 p.m.

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

Cannabis Law Report

JUNE 16, 2021

“Santé is a key partner to for Wake as they are a leading contract research organization (CRO) in Canada with expertise in advancing plant-based pharmaceutical products through various phases of clinical trial development. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

The Cannigma

MARCH 25, 2021

Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services. Largely it’s the opaque legal and regulatory restrictions on cannabis which complicate the matter.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Cannabis Law Report

AUGUST 23, 2021

FDA has not reviewed the manufacturing process of these unapproved CBD-containing drug products, so the manufacturing conditions of, or contaminant levels in, these products is unknown. Practicing veterinarians face a barrage of questions from pet owners about the use of CBD animal products for conditions ranging from arthritis to anxiety.

Pets 106

Pets Hemp CBD Food 106

Cannabis Law Report

JUNE 28, 2021

A FIVE-YEAR exclusive pharmaceutical distribution agreement has been signed between South West based Little Green Phrarma (LGP) and Medezin for the distribution of cannabis medicines into Poland. “Medezin’s distribution exclusivity is conditional upon it purchasing a minimum quota of products,” she said.

Pharmaceutical 65

Pharmaceutical Medicine Oil Conditions 65

Cannabis Law Report

OCTOBER 26, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Chapman has operated Chapman Pharmaceutical Consulting, Inc., About MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

The Joint Blog

JUNE 2, 2020

According to a new study published in the European Journal of Pain, delivering a precise doses of THC via a specialized inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions. 9 -Tetrahydrocannabinol (THC) in patients with chronic pain. 9 -THC: 0.5mg, 1mg, or a placebo. ?

Chronic Pain 58

Chronic Pain Clinical Trials Marijuana Safety 58

MMJ Recs

JULY 11, 2024

Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers.

Sleep 111

Sleep Treatment Research and Development Therapy 111